Almeida, M.; Soares, M.; Fonseca-Moutinho, J.; Ramalhinho, A.C.; Breitenfeld, L.
Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk. Pharmaceuticals 2021, 14, 94.
https://doi.org/10.3390/ph14020094
AMA Style
Almeida M, Soares M, Fonseca-Moutinho J, Ramalhinho AC, Breitenfeld L.
Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk. Pharmaceuticals. 2021; 14(2):94.
https://doi.org/10.3390/ph14020094
Chicago/Turabian Style
Almeida, Micaela, Mafalda Soares, José Fonseca-Moutinho, Ana Cristina Ramalhinho, and Luiza Breitenfeld.
2021. "Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk" Pharmaceuticals 14, no. 2: 94.
https://doi.org/10.3390/ph14020094
APA Style
Almeida, M., Soares, M., Fonseca-Moutinho, J., Ramalhinho, A. C., & Breitenfeld, L.
(2021). Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk. Pharmaceuticals, 14(2), 94.
https://doi.org/10.3390/ph14020094